Compare JXN & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JXN | CRL |
|---|---|---|
| Founded | 1961 | 1947 |
| Country | United States | United States |
| Employees | 3890 | N/A |
| Industry | Life Insurance | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2B | 8.6B |
| IPO Year | N/A | 1999 |
| Metric | JXN | CRL |
|---|---|---|
| Price | $105.81 | $186.26 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 12 |
| Target Price | $112.40 | ★ $198.27 |
| AVG Volume (30 Days) | 496.6K | ★ 849.4K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.13% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $15.15 | N/A |
| Revenue Next Year | $3.44 | $3.04 |
| P/E Ratio | $16.00 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $80.25 | $143.06 |
| 52 Week High | $123.61 | $228.88 |
| Indicator | JXN | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 47.02 | 62.44 |
| Support Level | $104.83 | $161.39 |
| Resistance Level | $109.34 | $197.12 |
| Average True Range (ATR) | 2.62 | 9.00 |
| MACD | -0.31 | 2.92 |
| Stochastic Oscillator | 43.68 | 96.22 |
Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.